These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11233903)

  • 1. Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation.
    Camargo LF; Uip DE; Simpson AA; Caballero O; Stolf NA; Vilas-Boas LS; Pannuti CS
    Transplantation; 2001 Feb; 71(3):412-7. PubMed ID: 11233903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
    Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
    J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].
    Özkarata E; Özbek ÖA; Avkan Oğuz V; Sayıner AA
    Mikrobiyol Bul; 2016 Jan; 50(1):44-52. PubMed ID: 27058328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of real-time polymerase chain reaction and antigenemia assay to detect cytomegalovirus in pediatric transplants].
    Farfán U MJ; Torres T JP; Vergara A A; Donoso W G; Alba G A; Paris D C; Santolaya De P ME
    Rev Chilena Infectol; 2011 Apr; 28(2):113-7. PubMed ID: 21720689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients.
    Humar A; Gregson D; Caliendo AM; McGeer A; Malkan G; Krajden M; Corey P; Greig P; Walmsley S; Levy G; Mazzulli T
    Transplantation; 1999 Nov; 68(9):1305-11. PubMed ID: 10573068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of cytomegalovirus positivity in the peripheral blood samples of risky patients by shell-vial cell culture, antigenemia test and real-time polymerase chain reaction].
    Gökahmetoğlu S; Yağmur G; Mutlu Sarıgüzel F; Deniz E
    Mikrobiyol Bul; 2011 Apr; 45(2):288-95. PubMed ID: 21644072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
    Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
    Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of cytomegalovirus DNA levels in intestinal biopsies as a diagnostic tool for CMV intestinal disease.
    Ganzenmueller T; Henke-Gendo C; Schlué J; Wedemeyer J; Huebner S; Heim A
    J Clin Virol; 2009 Nov; 46(3):254-8. PubMed ID: 19748823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
    Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
    J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patients.
    Niubò J; Pérez JL; Martínez-Lacasa JT; García A; Roca J; Fabregat J; Gil-Vernet S; Martín R
    Diagn Microbiol Infect Dis; 1996 Jan; 24(1):19-24. PubMed ID: 8988759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients.
    Kim DJ; Kim SJ; Park J; Choi GS; Lee S; Kwon CD; Ki C; Joh J
    Transplant Proc; 2007 Jun; 39(5):1458-60. PubMed ID: 17580161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
    Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
    Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of plasma quantitative polymerase chain reaction assay: diagnosis of cytomegalovirus infection in kidney transplant recipients.
    Rhee JY; Peck KR; Lee NY; Song JH
    Transplant Proc; 2011 Sep; 43(7):2624-9. PubMed ID: 21911135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation between symptomatic CMV infection and CMV antigenemia in heart allograft recipients.
    Koskinen PK; Nieminen MS; Mattila SP; Häyry PJ; Lautenschlager IT
    Transplantation; 1993 Mar; 55(3):547-51. PubMed ID: 8384383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of pp65 antigenemia for the early diagnosis of cytomegalovirus disease in patients with AIDS.
    Torrús D; Portilla J; Hernández-Aguado I; Boix V; Plazas J; Gimeno A; Torromé M; Llopis C; Valls V; Sánchez-Payá J
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):630-5. PubMed ID: 10534184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation.
    Weinberg A; Hodges TN; Li S; Cai G; Zamora MR
    J Clin Microbiol; 2000 Feb; 38(2):768-72. PubMed ID: 10655383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test.
    Dodt KK; Jacobsen PH; Hofmann B; Meyer C; Kolmos HJ; Skinhøj P; Norrild B; Mathiesen L
    AIDS; 1997 Mar; 11(3):F21-8. PubMed ID: 9147416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
    Mori T; Mori S; Kanda Y; Yakushiji K; Mineishi S; Takaue Y; Gondo H; Harada M; Sakamaki H; Yajima T; Iwao Y; Hibi T; Okamoto S
    Bone Marrow Transplant; 2004 Feb; 33(4):431-4. PubMed ID: 14676775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.